M 315 (Ondansetron 4 mg)

Pill imprint M 315 has been identified as Ondansetron hydrochloride 4 mg.

Ondansetron is used in the treatment of nausea/vomiting; alcohol dependence; gastroenteritis; obsessive compulsive disorder; nausea/vomiting, chemotherapy induced (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 4 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 315

Ondansetron hydrochloride 4 mg M 315
Ondansetron hydrochloride 4 mg M 315
Ondansetron hydrochloride
Imprint:
M
315
Strength:
4 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
5HT3 receptor antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0315
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0524 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)